-
Small interfering RNA (siRNA) is a class of double-stranded RNA molecules, about 20–25 nucleotides long, that act as genetic “switches” inside the cell. Once introduced, siRNA specifically recognizes and silences messenger RNA (mRNA) that carries the instructions to produce a mutated or disease-causing protein. This natural cellular mechanism is called RNA interference (RNAi).
-
A simplified step-by-step process:
The siRNA molecule is delivered into the cell
It binds precisely to the target mRNA with complementary sequence
The bound mRNA is degraded by the RNA-induced silencing complex (RISC)
This prevents the production of the mutated protein
Only the healthy allele remains active, allowing normal protein synthesis
-
High specificity: targets only the mutated gene, sparing the healthy one
Custom-designed: siRNA can be tailored to any known genetic mutation
Broad applicability: from rare genetic diseases to metabolic, cardiovascular and oncological conditions
Low off-target effects: advanced computational design minimizes unintended interactions
Our Approach
LOTO Interfering
Proprietary algorithms select the best siRNA candidates in silico
Preclinical validation on disease-specific cell and animal models
Patentable and scalable drug development process
Designed for rapid expansion into additional therapeutic areas including more common diseases with high clinical unmet needs